P Squared Asset Management Ag Exelixis, Inc. Put Options Transaction History

P Squared Asset Management Ag

  • $416 Million
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$21.96 - $27.6 $134,153 - $168,608
6,109 Added 98.15%
12,333 $320,000
Q2 2024

Aug 13, 2024
SELL
$20.34 - $23.73 $171,995 - $200,660
-8,456 Reduced 57.6%
6,224 $139,000
Q1 2024

May 14, 2024
BUY
$20.17 - $23.93 $13,715 - $16,272
680 Added 4.86%
14,680 $348,000
Q3 2023

Nov 13, 2023
BUY
$19.04 - $22.74 $266,560 - $318,360
14,000 New
14,000 $305,000

Others Institutions Holding EXEL

# of Institutions
502
Shares Held
243M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track P Squared Asset Management Ag Portfolio

Follow P Squared Asset Management Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of P Squared Asset Management Ag, based on Form 13F filings with the SEC.

News

Stay updated on P Squared Asset Management Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email